MedTrace Logo

A Pilot Study of Synbiotics in Adults With Depressive Symptoms

NCT06905223 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-06-08

No results posted yet for this study

Summary

This study aims to explore the efficacy and safety of a synbiotic formula (MQU10) in improving mood and well-being in adults with mild to moderate depressive symptoms.

Conditions

  • Depressive Symptoms Mild to Moderate in Severity

Interventions

DIETARY_SUPPLEMENT

MQU10

MQU10 consists of a blend of food-grade probiotic strains (20 billion CFU daily) and prebiotic compounds.

Sponsors & Collaborators

  • GenieBiome Limited

    lead INDUSTRY

Principal Investigators

  • Jessica Ching, PhD · GenieBiome Limited

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-03
Primary Completion
2026-03-25
Completion
2027-09-26

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06905223 on ClinicalTrials.gov